Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Critical Care (London, England)
|
June 16, 2004
Iron supplementation in the intensive care unit: when, how much, and by what route?
Marc Lapointe
Clinical Therapeutics
|
July 21, 2004
Is there a place for epoetin alfa in managing anemia during critical illness?
Marlea Givens, Marc Lapointe
Pharmacotherapy
|
April 12, 2003
The hypothalamic-pituitary-adrenal axis and low-dose glucocorticoids in the treatment of septic shock
David R Williamson, Marc Lapointe
Epilepsy Currents
|
April 28, 2009
Clinical perspectives on lacosamide
Jonathan J Halford, Marc Lapointe
Biochemical and Biophysical Research Communications
|
July 9, 2013
Obesity-inducing diet promotes acylation stimulating protein resistance
Alexandre Fisette, Marc Lapointe, Katherine Cianflone
American Journal of Pharmaceutical Education
|
September 25, 2009
A peer review process for classroom teaching
Marlea G Wellein, Kelly R Ragucci, Marc Lapointe
Journal of Dermatological Science
|
September 12, 2008
Development of an in vitro psoriatic skin model by tissue engineering
Jessica Jean, Marc Lapointe, Jacques Soucy, et al.
Neurocritical Care
|
October 31, 2007
Intraventricular nicardipine for refractory cerebral vasospasm after subarachnoid hemorrhage
Kelly Goodson, Marc Lapointe, Timothy Monroe, et al.
Molecular Immunology
|
September 22, 2009
Recombinant C3adesArg/acylation stimulating protein (ASP) is highly bioactive: a critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation
Wei Cui, Marc Lapointe, Danny Gauvreau, et al.
Journal of Obesity
|
May 6, 2014
Complement receptors C5aR and C5L2 are associated with metabolic profile, sex hormones, and liver enzymes in obese women pre- and postbariatric surgery
Reza Rezvani, Jessica Smith, Marc Lapointe, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Critical Care (London, England)
|
June 16, 2004
Iron supplementation in the intensive care unit: when, how much, and by what route?
Marc Lapointe
Clinical Therapeutics
|
July 21, 2004
Is there a place for epoetin alfa in managing anemia during critical illness?
Marlea Givens, Marc Lapointe
Pharmacotherapy
|
April 12, 2003
The hypothalamic-pituitary-adrenal axis and low-dose glucocorticoids in the treatment of septic shock
David R Williamson, Marc Lapointe
Epilepsy Currents
|
April 28, 2009
Clinical perspectives on lacosamide
Jonathan J Halford, Marc Lapointe
Biochemical and Biophysical Research Communications
|
July 9, 2013
Obesity-inducing diet promotes acylation stimulating protein resistance
Alexandre Fisette, Marc Lapointe, Katherine Cianflone
American Journal of Pharmaceutical Education
|
September 25, 2009
A peer review process for classroom teaching
Marlea G Wellein, Kelly R Ragucci, Marc Lapointe
Journal of Dermatological Science
|
September 12, 2008
Development of an in vitro psoriatic skin model by tissue engineering
Jessica Jean, Marc Lapointe, Jacques Soucy, et al.
Neurocritical Care
|
October 31, 2007
Intraventricular nicardipine for refractory cerebral vasospasm after subarachnoid hemorrhage
Kelly Goodson, Marc Lapointe, Timothy Monroe, et al.
Molecular Immunology
|
September 22, 2009
Recombinant C3adesArg/acylation stimulating protein (ASP) is highly bioactive: a critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation
Wei Cui, Marc Lapointe, Danny Gauvreau, et al.
Journal of Obesity
|
May 6, 2014
Complement receptors C5aR and C5L2 are associated with metabolic profile, sex hormones, and liver enzymes in obese women pre- and postbariatric surgery
Reza Rezvani, Jessica Smith, Marc Lapointe, et al.
Page
of 4